Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.62 |
| ▸ | PKM | P14618 | 1/20 | 0.62 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.55 |
| ▸ | IDO1 | P14902 | 2/20 | 0.52 |
| ▸ | HTT | P42858 | 3/20 | 0.52 |
| ▸ | NPC1 | O15118 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | GAA | P10253 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | F2RL1 | P55085 | 1/20 | 0.50 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.50 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL15660534 | 0.98 | ALDH1A1 (0.60) | ALDH1A1PKMCHRM2IDO1HTT | |
| SCHEMBL25191115 | 0.90 | MAPT (0.63) | ALDH1A1PKMCHRM2HTTNPC1 | |
| SCHEMBL8545698 | 0.85 | ALDH1A1 (0.49) | ALDH1A1PKMHTTMEN1KMT2A | |
| SCHEMBL3388335 | 0.84 | CHRM2 (0.58) | ALDH1A1PKMCHRM2HTTMEN1 | |
| SCHEMBL121529 | 0.81 | CHRM2 (0.70) | ALDH1A1PKMCHRM2IDO1HTT | |
| SCHEMBL7346729 | 0.81 | ALDH1A1 (0.61) | ALDH1A1PKMCHRM2IDO1HTT | |
| Hydrochloric Acid SCHEMBL7034100 | 0.79 | ALDH1A1 (0.59) | ALDH1A1PKMCHRM2IDO1HTT | |
| Hydrochloric Acid SCHEMBL2147064 | 0.79 | CHRM2 (0.68) | ALDH1A1PKMCHRM2HTTGAA | |
| SCHEMBL8278372 | 0.79 | IDO1 (0.60) | ALDH1A1PKMCHRM2IDO1HTT | |
| Hydrochloric Acid SCHEMBL9479560 | 0.79 | CHRM2 (0.68) | ALDH1A1PKMCHRM2HTTGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121850924-A | Curing stabilizer, sealant based on curing stabilizer and preparation method of sealant | 广州白云科技股份有限公司 | 2026-04-14 | — | — | CN | disclosed |
| EP-4703355-A1 | FLUORINE-CONTAINING ISOXAZOLONE COMPOUND AND PRODUCTION METHOD FOR SAME | Unimatec Co., Ltd. (JP) | 2026-03-04 | — | — | EP | disclosed |
| WO-2024225214-A1 | FLUORINE-CONTAINING ISOXAZOLONE COMPOUND AND PRODUCTION METHOD FOR SAME | ユニマテック株式会社 | 2024-10-31 | — | — | WO | disclosed |
| US-20240294470-A1 | FRAGRANCE COMPOUNDS | GIVAUDAN SA (CH) | 2024-09-05 | — | — | US | disclosed |
| EP-4355728-A1 | FRAGRANCE COMPOUNDS | Givaudan SA (CH) | 2024-04-24 | — | — | EP | disclosed |
| CN-117500783-A | Perfume compounds | 奇华顿股份有限公司 | 2024-02-02 | — | — | CN | disclosed |
| WO-2022261956-A1 | FRAGRANCE COMPOUNDS | GIVAUDAN SA (CH) | 2022-12-22 | — | — | WO | disclosed |
| WO-2022263605-A1 | FRAGRANCE COMPOUNDS | GIVAUDAN SA (CH) | 2022-12-22 | — | — | WO | disclosed |
| WO-2022068933-A1 | COMPOUNDS AND METHODS OF TREATING DISEASES | CULLGEN (SHANGHAI) , INC. (CN) | 2022-04-07 | — | — | WO | disclosed |
| CN-107108657-B | Tosylate salt of compound | 伊莱利利公司 | 2021-10-08 | — | — | CN | disclosed |
| EP-0740652-A1 | METALLOPROTEINASE INHIBITORS | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 1996-11-06 | — | — | EP | disclosed |
| WO-1995019956-A1 | METALLOPROTEINASE INHIBITORS | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 1995-07-27 | — | — | WO | disclosed |
| EP-0641327-A1 | NOVEL ALPHA-MANNOSIDASE INHIBITORS | MERRELL PHARMACEUTICALS INC. (US) | 1995-03-08 | — | — | EP | disclosed |
| EP-0641327-A4 | NOVEL ALPHA-MANNOSIDASE INHIBITORS. | MERRELL DOW PHARMA (US) | 1994-06-01 | — | — | EP | disclosed |
| US-5262425-A | Immunostimulants, chemoprotective and radioprotective agents, antimetastatic agents | MERRELL DOW PHARMACEUTICALS INC. (US) | 1993-11-16 | — | — | US | disclosed |
| WO-1993005781-A1 | NOVEL ALPHA-MANNOSIDASE INHIBITORS | MERRELL DOW PHARMACEUTICALS INC. (US) | 1993-04-01 | — | — | WO | disclosed |
| EP-0223588-B1 | PROCESS FOR THE PREPARATION OF BETA-LACTAM COMPOUNDS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1991-06-12 | — | — | EP | disclosed |
| EP-0310061-A1 | 5-Mono or Disubstituted-3-(phenyl or 2-naphthalenyl)-3-[(1H-imidazol-1-ylmethyl) or (1H-1,2,4-triazol-1-ylmethyl)]-2-(methyl or benzyl)isoxazolidines | FISONS CORPORATION (US) | 1989-04-05 | — | — | EP | disclosed |
| US-4749793-A | 5-substituted-3-phenyl-3-[1H-imidazol-1-ylmethyl) or (1H-1,2,4-triazol-1-ylmethyl]-2-benzylisoxazolidines (ir 3011) | PENNWALT CORPORATION (US) | 1988-06-07 | — | — | US | disclosed |
| EP-0223588-A1 | Process for the preparation of beta-lactam compounds | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1987-05-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240294470-A1 | FRAGRANCE COMPOUNDS | FASN, FAAH2, FADS2 | ALDH1A1 27/4885PKM 310/4885CHRM2 4042/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.